Literature DB >> 3490265

A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis.

D C Briggs, K Welsh, R S Pereira, C M Black.   

Abstract

Allotyping of the major histocompatibility complex (MHC)-linked complement component C4 has revealed a strong association of the null allele, C4A*Q0, with systemic sclerosis (SSc). Sixty-four percent of patients with SSc carried the C4A*Q0 allele, compared with 17% of the control group. Twenty-five patients and their families were typed for HLA antigens (A, B, Cw, and DR) and the MHC-linked complement components C4 and factor B to identify haplotypes in the MHC linkage group and C4 null alleles. Strong allelic association of HLA-B8 and DR3 with C4A*Q0 probably explains the previously reported association of SSc with the extended haplotype carrying HLA-B8 and DR3. Ninety-two percent of the patients had either C4A*Q0 or DR5; 31% of the controls had either C4A*Q0 or DR5.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490265     DOI: 10.1002/art.1780291014

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

Review 1.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes.

Authors:  G Rittner; G Schwanitz; M P Baur; C M Black; K I Welsh; P Kühnl; C Rittner
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

3.  Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).

Authors:  J D Reveille; D Owerbach; R Goldstein; R Moreda; R A Isern; F C Arnett
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

4.  Increased frequency of the null allele at the complement C4b locus in autism.

Authors:  R P Warren; V K Singh; P Cole; J D Odell; C B Pingree; W L Warren; E White
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

5.  Primary sclerosing cholangitis associated with systemic sclerosis.

Authors:  G Fraile; J L Rodríguez-García; A Moreno
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

6.  Influence of C4 null alleles on C4 activation in systemic lupus erythematosus.

Authors:  D C Briggs; G Senaldi; D A Isenberg; K I Welsh; D Vergani
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

7.  The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

Authors:  M Kuwana; J Kaburaki; Y Okano; H Inoko; K Tsuji
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).

Authors:  J D Reveille; E Durban; M J MacLeod-St Clair; R Goldstein; R Moreda; R D Altman; F C Arnett
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Complement profile in primary biliary cirrhosis.

Authors:  M Schlesinger; C Benbassat; Y Shoenfeld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

10.  Real-time PCR quantification of human complement C4A and C4B genes.

Authors:  Agnes Szilagyi; Bernadett Blasko; Denes Szilassy; George Fust; Maria Sasvari-Szekely; Zsolt Ronai
Journal:  BMC Genet       Date:  2006-01-10       Impact factor: 2.797

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.